Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Risk increases by 4% for every 10g of alcohol consumed
Just three alcoholic drinks a day could be enough to cause liver cancer
Research review found the risk increased by 4 per cent for every 10g
Experts also found a strong association between obesity and liver cancer
World Cancer Research Fund analysed 34 studies, covering 8.2m people
The immune system uses T cells, which are immune cells, to fight cancer and other pathogen-infected cells.Cancer stops this activity by using ...
"Advanced forms of cancer are able to progress due to the immune system's inability to recognize the threat." Kalorama estimates a $100 billion-dollar ...
(Nanowerk Spotlight) Early and accurate detection of cancer is critical for successfulcancer .... IgG antibody is a key component of our immune system.
"Recent successes in harnessing the immune system to combat cancer are evidence for the significant roles of a cancer patient's immune responses ...
The longer HPV persists the more likely it is to lead to cancer, including ... “There is no doubt that the immune system plays a role in HPV clearance,” ...
Another strategy to fight advanced melanoma relies on immunotherapies, i.e., a treatment that uses patients' own immune system to attack cancer ...
His work has appeared in Nature India, Lab Times, Decoded Science, Cancer InCytes, the AAPS (American Association of Pharmaceutical Sciences) ...
One theory holds that cells with greater number of mutations are able to trigger an aggressive immune system response against cancer cells, while ...
The Food and Drug Administration (FDA) has approved immunotherapies for prostate cancer, advanced kidney cancer, lymphoma, and metastatic ...
Emerging evidence suggests that immunotherapy may play an important role in treating prostate cancer. In particular, preliminary results have shown ...
Median survival rates rose beyond 10 years for intraperitoneal therapy in gross residual disease. Read more
Human Gallbladder and Pancreas Anatomy Scientists at UCLA's California NanoSystems Institute and Jonsson Comprehensive Cancer Center have ...
“With certain BRCA mutations there is an increased risk of pancreatic cancer, prostate cancer,” Yamada said. “There is a big ripple effect with one ...
Angelina Jolie's message: 'Choose what's right for you'; experts agree - Los Angeles Times
The Company is planning a Phase I clinical trial of Adva-27a for pancreatic cancer in parallel to the Phase I clinical trial of Adva-27a for multidrug ...
"Perhaps the biggest potential breakthrough for PharmaCyte is the use of their Cell-in-a-Box technology on pancreatic cancer. PharmaCyte owns the ...
Intraperitoneal Chemotherapy Improves 10-Year Ovarian Cancer Survival
Intraperitoneal chemotherapy for treatment of ovarian cancer resulted in a survival benefit that extended past 10 years compared with intravenous chemotherapy.
Intraperitoneal chemotherapy for treatment of ovarian cancer resulted in a survival benefit that extended past 10 years compared with intravenous chemotherapy.
Should Drug Approvals Be Based on Progression-Free Survival?
A study found varying degrees of costs and benefits associated with granting early access to drugs based on PFS. In many cases, costs outstripped the benefits.
A study found varying degrees of costs and benefits associated with granting early access to drugs based on PFS. In many cases, costs outstripped the benefits.
Early-Onset Alopecia May Signal Chemotherapy Response for Ovarian Cancer
Onset of alopecia within the first 3 cycles of chemotherapy was associated with improved survival in ovarian cancer patients who completed 6 cycles of chemo.
Onset of alopecia within the first 3 cycles of chemotherapy was associated with improved survival in ovarian cancer patients who completed 6 cycles of chemo.
Cardiovascular Disease Risk in Prostate Cancer Patients on ADT
The FDA requires a risk label on GnRH agonists that indicates the increased risk of cardiovascular disease and diabetes in prostate cancer patients.
The FDA requires a risk label on GnRH agonists that indicates the increased risk of cardiovascular disease and diabetes in prostate cancer patients.
Donor Type Did Not Influence Transplant Outcome in High-Risk Pediatric ALL
Stem cell transplantation from an HLA-genoidentical sibling or an HLA-matched unrelated donor did not affect outcomes among high-risk pediatric ALL patients.
Stem cell transplantation from an HLA-genoidentical sibling or an HLA-matched unrelated donor did not affect outcomes among high-risk pediatric ALL patients.
Crizotinib Yields High Response Rates in ROS1-Rearranged Lung Cancer
A retrospective analysis showed that crizotinib is highly active in lung cancer with ROS1 rearrangements, which are present in about 1% of lung adenocarcinomas.
A retrospective analysis showed that crizotinib is highly active in lung cancer with ROS1 rearrangements, which are present in about 1% of lung adenocarcinomas.
Later-Line PD-1 Inhibitor Improves Melanoma Outcomes
Advanced melanoma patients who progressed on ipilimumab were more likely to achieve an objective response when treated with nivolumab than with chemotherapy.
Advanced melanoma patients who progressed on ipilimumab were more likely to achieve an objective response when treated with nivolumab than with chemotherapy.
Statins Linked With Reduced Liver Cancer in Low-Rate Areas
Current use of statins was associated with about a 50% decreased risk for liver cancer, according to results of a study looking at data from the United Kingdom.
Current use of statins was associated with about a 50% decreased risk for liver cancer, according to results of a study looking at data from the United Kingdom.
Radiation Response in Breast Cancer Bone Metastases
Researchers were able to demonstrate response to radiotherapy in breast cancer patients with osteolytic metastases by measuring increases in bone density.
Researchers were able to demonstrate response to radiotherapy in breast cancer patients with osteolytic metastases by measuring increases in bone density.
Bone Metastases in Gastrointestinal Stromal Tumors
The risk of bone metastases from GISTs, though rare, should be considered during long-term follow-up of patients, especially in those with liver metastases.
The risk of bone metastases from GISTs, though rare, should be considered during long-term follow-up of patients, especially in those with liver metastases.
Science Daily Cancer News
Magnetic nanoparticles can open the blood-brain barrier and deliver molecules directly to the brain, say researchers. This barrier runs inside almost all vessels in the brain and protects it from elements circulating in the blood that may be toxic to the brain. The research is important as currently 98% of therapeutic molecules are also unable to cross the blood-brain barrier.
A multi-disciplinary team of doctors and scientists has characterized the genetic changes associated with the spread of colorectal cancer to the liver. Most patients are initially diagnosed with an early stage disease. However, a proportion of these patients will develop a recurrence of the cancer (metastasis), typically in the liver, one to three years after their colon surgery. If identified early, the liver metastasis may be amenable to surgical removal, and cure may still be possible.
A compound that delays leukemia in mice and effectively kills leukemia cells in human tissue samples has been developed by researchers, raising hopes that the drug could lead to improved treatments in people. The researchers call it an exciting 'new paradigm' for treating leukemia, they say.
Leukemia cells from patients suffering from chronic myeloid leukemia, especially in the advanced stage, lack one of the proteins: the famous BRCA1. Importantly, the protein is not present even if the patient carries the proper, not mutated gene responsible for BRCA1 production.
Researchers have provided early evidence to suggest that a blood test could be used to identify bowel cancer patients that may benefit from more intensive chemotherapy.
Tambahkan Komentar